BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 2174864)

  • 1. Nucleotide sequence and characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones.
    Yoshida H; Bogaki M; Nakamura S; Ubukata K; Konno M
    J Bacteriol; 1990 Dec; 172(12):6942-9. PubMed ID: 2174864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characterization of the Staphylococcus aureus norA gene, which confers resistance to hydrophilic quinolones].
    Yoshida H
    Nihon Rinsho; 1992 May; 50(5):1042-8. PubMed ID: 1324331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quinolone resistance mediated by norA: physiologic characterization and relationship to flqB, a quinolone resistance locus on the Staphylococcus aureus chromosome.
    Ng EY; Trucksis M; Hooper DC
    Antimicrob Agents Chemother; 1994 Jun; 38(6):1345-55. PubMed ID: 8092836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A point mutation in norA gene is responsible for quinolone resistance in Staphylococcus aureus.
    Ohshita Y; Hiramatsu K; Yokota T
    Biochem Biophys Res Commun; 1990 Nov; 172(3):1028-34. PubMed ID: 2173911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning and expression of the norA gene for fluoroquinolone resistance in Staphylococcus aureus.
    Ubukata K; Itoh-Yamashita N; Konno M
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1535-9. PubMed ID: 2817852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus.
    Kaatz GW; Seo SM; Ruble CA
    Antimicrob Agents Chemother; 1993 May; 37(5):1086-94. PubMed ID: 8517696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrophilicity of quinolones is not an exclusive factor for decreased activity in efflux-mediated resistant mutants of Staphylococcus aureus.
    Takenouchi T; Tabata F; Iwata Y; Hanzawa H; Sugawara M; Ohya S
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1835-42. PubMed ID: 8843290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of 4-quinolone resistance in quinolone-resistant and methicillin-resistant Staphylococcus aureus isolates from Japan and China.
    Tanaka M; Zhang YX; Ishida H; Akasaka T; Sato K; Hayakawa I
    J Med Microbiol; 1995 Mar; 42(3):214-9. PubMed ID: 7884804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative activity of ozenoxacin and other quinolones in Staphylococcus aureus strains overexpressing the efflux pump-encoding genes mepA and norA.
    López Y; Tato M; Gargallo-Viola D; Cantón R; Vila J; Zsolt I
    Int J Antimicrob Agents; 2020 Sep; 56(3):106082. PubMed ID: 32659467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of NorR protein, a multifunctional regulator of norA expression in Staphylococcus aureus.
    Truong-Bolduc QC; Zhang X; Hooper DC
    J Bacteriol; 2003 May; 185(10):3127-38. PubMed ID: 12730173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA cloning and organization of the Staphylococcus aureus gyrA and gyrB genes: close homology among gyrase proteins and implications for 4-quinolone action and resistance.
    Hopewell R; Oram M; Briesewitz R; Fisher LM
    J Bacteriol; 1990 Jun; 172(6):3481-4. PubMed ID: 2160946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emr, an Escherichia coli locus for multidrug resistance.
    Lomovskaya O; Lewis K
    Proc Natl Acad Sci U S A; 1992 Oct; 89(19):8938-42. PubMed ID: 1409590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inducible NorA-mediated multidrug resistance in Staphylococcus aureus.
    Kaatz GW; Seo SM
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2650-5. PubMed ID: 8592996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efflux-mediated response of Staphylococcus aureus exposed to ethidium bromide.
    Couto I; Costa SS; Viveiros M; Martins M; Amaral L
    J Antimicrob Chemother; 2008 Sep; 62(3):504-13. PubMed ID: 18511413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel locus conferring fluoroquinolone resistance in Staphylococcus aureus.
    Trucksis M; Wolfson JS; Hooper DC
    J Bacteriol; 1991 Sep; 173(18):5854-60. PubMed ID: 1653224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NorA plasmid resistance to fluoroquinolones: role of copy number and norA frameshift mutations.
    Sun L; Sreedharan S; Plummer K; Fisher LM
    Antimicrob Agents Chemother; 1996 Jul; 40(7):1665-9. PubMed ID: 8807059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in the DNA topoisomerase IV grlA gene responsible for quinolone resistance in Staphylococcus aureus.
    Yamagishi J; Kojima T; Oyamada Y; Fujimoto K; Hattori H; Nakamura S; Inoue M
    Antimicrob Agents Chemother; 1996 May; 40(5):1157-63. PubMed ID: 8723458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning and sequencing of a novel gene (recG) that affects the quinolone susceptibility of Staphylococcus aureus.
    Niga T; Yoshida H; Hattori H; Nakamura S; Ito H
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1770-4. PubMed ID: 9257758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MgrA is a multiple regulator of two new efflux pumps in Staphylococcus aureus.
    Truong-Bolduc QC; Dunman PM; Strahilevitz J; Projan SJ; Hooper DC
    J Bacteriol; 2005 Apr; 187(7):2395-405. PubMed ID: 15774883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quinolone susceptibility of norA-disrupted Staphylococcus aureus.
    Yamada H; Kurose-Hamada S; Fukuda Y; Mitsuyama J; Takahata M; Minami S; Watanabe Y; Narita H
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2308-9. PubMed ID: 9333072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.